X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
index medicus (26) 26
melanoma (20) 20
preferentially expressed antigen of melanoma (16) 16
antigens, neoplasm - genetics (15) 15
minimal residual disease (15) 15
gene-expression (14) 14
oncology (14) 14
preferentially expressed antigen (14) 14
prognosis (14) 14
acute myeloid-leukemia (13) 13
immunotherapy (13) 13
prame (13) 13
female (12) 12
hematology (12) 12
antigens (11) 11
antigens, neoplasm - metabolism (11) 11
leukemia (11) 11
gene expression (10) 10
middle aged (10) 10
adult (9) 9
breast-cancer (9) 9
cancer (9) 9
male (9) 9
tumors (9) 9
antigen (8) 8
dna methylation (8) 8
aged (7) 7
aged, 80 and over (7) 7
breast cancer (7) 7
cells (7) 7
melanoma prame (7) 7
gene expression regulation, neoplastic (6) 6
messenger-rna levels (6) 6
acute lymphoblastic-leukemia (5) 5
biomarkers, tumor - metabolism (5) 5
care and treatment (5) 5
cell line, tumor (5) 5
chemotherapy (5) 5
gene (5) 5
genes (5) 5
hypomethylation (5) 5
identification (5) 5
acute leukemia (4) 4
acute myeloid leukemia (4) 4
adolescent (4) 4
analysis (4) 4
antigens, neoplasm - biosynthesis (4) 4
biomarkers, tumor - genetics (4) 4
genetic aspects (4) 4
immunohistochemistry (4) 4
medicine (4) 4
patients (4) 4
preferentially expressed antigen in melanoma (4) 4
proteins (4) 4
receptor (4) 4
relevance (4) 4
t-cells (4) 4
young adult (4) 4
animals (3) 3
antigens, neoplasm - analysis (3) 3
basic cancer research (3) 3
bone marrow (3) 3
carcinoma (3) 3
clinical importance (3) 3
dendritic cells (3) 3
deoxyribonucleic acid--dna (3) 3
diagnosis (3) 3
disease-free survival (3) 3
epigenetics (3) 3
hemic and lymphatic diseases (3) 3
histocompatibility antigen hla (3) 3
immunotherapy - methods (3) 3
k562 cells (3) 3
kinases (3) 3
leukemia, myeloid, acute - genetics (3) 3
lymphocytes (3) 3
lymphocytes t (3) 3
medical laboratory technology (3) 3
medicine, research & experimental (3) 3
methylation (3) 3
multidisciplinary sciences (3) 3
myelodysplastic syndromes - genetics (3) 3
neoplasms - metabolism (3) 3
original paper (3) 3
progression (3) 3
research (3) 3
research article (3) 3
science (3) 3
t cell receptors (3) 3
tumor-associated antigens (3) 3
abridged index medicus (2) 2
acute myelogenous leukemia (2) 2
antigen prame (2) 2
antigen presentation (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
apoptosis (2) 2
azacitidine - pharmacology (2) 2
biochemistry (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 06/2017, Volume 127, Issue 7, pp. 2705 - 2718
Journal Article
Journal Article
Journal Article
Journal Article
Gastrointestinal Tumors, ISSN 2296-3774, 03/2017, Volume 3, Issue 3-4, pp. 128 - 135
Background: Retinoids, vitamin A and its derivatives, have an antitumor effect on hepatocellular carcinoma (HCC). The function of retinoids is exerted by the... 
Original Paper | Preferentially expressed antigen of melanoma | Hepatocellular carcinoma | Prognosis | Corepressor | Retinoic acid
Journal Article
International Journal of Cancer, ISSN 0020-7136, 11/2008, Volume 123, Issue 9, pp. 2130 - 2137
The mortality rate for patients with ovarian carcinomas is high and the available prognostic factors are insufficient. The use of biomarkers may contribute to... 
capping protein (actin filament) gelsolin‐like | clusterin | preferentially expressed antigen in melanoma | ovarian cancer | biomarkers | integrin beta 3 | Biomarkers | Capping protein (actin filament) gelsolin-like | Integrin beta 3 | Preferentially expressed antigen in melanoma | Clusterin | Ovarian cancer | capping protein (actin filament) gelsolin-like | ACTIN-MODULATING PROTEIN | CYTOPLASMIC CLUSTERIN | TUMORS | GELSOLIN | BREAST-CANCER CELLS | INTEGRIN ALPHA-V-BETA-3 | OVEREXPRESSION | MELANOMA | ONCOLOGY | GENE-EXPRESSION | CARCINOMA | Immunohistochemistry | Integrin beta3 - analysis | Adenocarcinoma - pathology | Nuclear Proteins - analysis | Prognosis | Clusterin - analysis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - mortality | Cystadenocarcinoma, Serous - pathology | Polymerase Chain Reaction | Aged, 80 and over | Adult | Female | Integrin beta3 - genetics | Antigens, Neoplasm - analysis | Nuclear Proteins - genetics | Microfilament Proteins - genetics | Antigens, Neoplasm - genetics | Clusterin - genetics | Biomarkers, Tumor - analysis | Microfilament Proteins - analysis | Cystadenocarcinoma, Serous - mortality | Aged | Neoplasm Staging | Adenocarcinoma - mortality | Index Medicus | Biokemi och molekylärbiologi | Biochemistry and Molecular Biology | MEDICIN OCH HÄLSOVETENSKAP | MEDICAL AND HEALTH SCIENCES
Journal Article
岩手医学雑誌, ISSN 0021-3284, 08/2008, Volume 60, pp. 187 - 195
Journal Article
JOURNAL OF TRANSLATIONAL MEDICINE, ISSN 1479-5876, 01/2019, Volume 17, Issue 1, pp. 9 - 9
Journal Article
Annals of Hematology, ISSN 0939-5555, 8/2016, Volume 95, Issue 8, pp. 1233 - 1240
This study investigated the efficacy of minimal residual disease (MRD) monitoring and MRD-directed preemptive immunotherapy in high-risk myelodysplastic... 
Allogeneic hematopoietic stem cell transplantation | Medicine & Public Health | Hematology | Wilms’ tumor gene 1 | Preferentially expressed antigen of melanoma | Minimal residual disease | Oncology | Myelodysplastic syndromes | DONOR LYMPHOCYTE INFUSIONS | ACUTE MYELOID-LEUKEMIA | TUMOR GENE-1 EXPRESSION | ACUTE LEUKEMIA/MYELODYSPLASTIC SYNDROME | RELAPSE | INTERFERON-ALPHA | Wilms' tumor gene 1 | ACUTE LYMPHOBLASTIC-LEUKEMIA | SALVAGE THERAPY | PRAME | FLOW-CYTOMETRY | HEMATOLOGY | Outcome Assessment (Health Care) - methods | Multivariate Analysis | Immunotherapy - methods | Neoplasm, Residual - metabolism | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Transplantation, Homologous | Myelodysplastic Syndromes - therapy | Flow Cytometry | Neoplasm, Residual - diagnosis | Adult | Female | Child | WT1 Proteins - genetics | Antigens, Neoplasm - genetics | Myelodysplastic Syndromes - metabolism | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Immunophenotyping | Reverse Transcriptase Polymerase Chain Reaction | Neoplasm, Residual - genetics | Outcome Assessment (Health Care) - statistics & numerical data | Adolescent | Myelodysplastic Syndromes - genetics | Hematopoietic Stem Cell Transplantation - methods | Antigens | Analysis | Immunotherapy | Leukemia | Melanoma | Stem cells | Transplantation | Hematopoietic stem cells | Index Medicus
Journal Article
Leukemia Research, ISSN 0145-2126, 2012, Volume 36, Issue 7, pp. 895 - 899